|
Volumn 335, Issue 7613, 2007, Pages 219-220
|
Hormone replacement therapy comes full circle
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONJUGATED ESTROGEN;
ESTROGEN;
HORMONE;
MEDROXYPROGESTERONE ACETATE;
PLACEBO;
ARTERY CALCIFICATION;
ATHEROSCLEROSIS;
BREAST CANCER;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COLORECTAL CANCER;
DEEP VEIN THROMBOSIS;
DEMENTIA;
DISEASE COURSE;
DOSE RESPONSE;
DRUG DOSE INCREASE;
DRUG EFFECT;
EDITORIAL;
GALLBLADDER DISEASE;
HIP FRACTURE;
HORMONE SUBSTITUTION;
HOT FLUSH;
HUMAN;
ISCHEMIC HEART DISEASE;
LOW DRUG DOSE;
MEDICAL INFORMATION;
MENOPAUSE;
MORTALITY;
NIGHT SWEAT;
PRIORITY JOURNAL;
RISK FACTOR;
STROKE;
VAGINAL DRYNESS;
VENOUS THROMBOEMBOLISM;
WOMEN'S HEALTH;
AGED;
CONTROLLED CLINICAL TRIAL;
FEMALE;
MIDDLE AGED;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
AGED;
CARDIOVASCULAR DISEASES;
FEMALE;
HORMONE REPLACEMENT THERAPY;
HUMANS;
MENOPAUSE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
WOMEN'S HEALTH;
|
EID: 34547813676
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.39272.445428.80 Document Type: Editorial |
Times cited : (7)
|
References (10)
|